BRANMOOR
THURSDAY · 14 MAY 2026

FDA Recall D-0236-2024

Insight Pharmaceuticals LLC, a Prestige Consumer Healthcare company · Tarrytown, NY

Class I — life-threatening Completed 875 days on record

Highest impact — Class I recall — FDA determination of strong likelihood of serious adverse health consequence or death.

Product

Americaine, (benzocaine 20%) Benzocaine Topical Anesthetic Spray, Aerosol Can 2 oz (57 G), Dist. by Insight Pharmaceuticals Corp. Tarrytown, NY 10591, USA, A Prestige Consumer Healthcare company. Made in India. NDC 63736-378-02, Can UPC 3 63736 37882 0; Case UPC 1 03 63736 37882 7

Lot / code: Lot # 1A16420, exp. date 01/31/2025

Quantity: 34,704 cans

Reason for recall

Chemical Contamination: presence of benzene

Recall record

Recall number
D-0236-2024
Classification
Class I
Status
Completed
Voluntary or mandated
Voluntary: Firm initiated
Firm notification
Letter
Distribution
Nationwide in the USA
Recall initiated
2023-12-21
Classified by FDA Center
2024-01-17
FDA published
2024-01-24
Recalling firm
Insight Pharmaceuticals LLC, a Prestige Consumer Healthcare company
Firm location
Tarrytown, NY

Drug identification

Brand name(s)
AMERICAINE
Generic name(s)
BENZOCAINE
Manufacturer(s)
Insight Pharmaceuticals LLC
NDC(s)
63736-378
Route(s)
TOPICAL

‹ All recalls